Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation (Journal of Hematology & Oncology, (2022), 15, 1, (109), 10.1186/s13045-022-01330-3)

Muhammad Elnaggar, Sarita Agte, Paula Restrepo, Meghana Ram, David Melnekoff, Christos Adamopoulos, Mark M. Stevens, Katerina Kappes, Violetta Leshchenko, Daniel Verina, Sundar Jagannath, Poulikos I. Poulikakos, Samir Parekh, Alessandro Laganà

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation (Journal of Hematology & Oncology, (2022), 15, 1, (109), 10.1186/s13045-022-01330-3)'. Together they form a unique fingerprint.

Medicine & Life Sciences